Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice. - Wikidata - awgldk - TriplyDB

Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice.

Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice.

http://www.wikidata.org/entity/Q40344535

about

Zika Virus: the Latest Newcomer Complement activation is required for induction of a protective antibody response against West Nile virus infection Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis.Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus CD8+ T Cells Require Perforin To Clear West Nile Virus from Infected Neurons Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc Receptor-Dependent and -Independent Mechanisms Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus Gamma Interferon Plays a Crucial Early Antiviral Role in Protection against West Nile Virus Infection Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile Virus CD4+ T-Cell Responses Are Required for Clearance of West Nile Virus from the Central Nervous System Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein Defining Limits of Treatment with Humanized Neutralizing Monoclonal Antibody for West Nile Virus Neurological Infection in a Hamster Model CD40-CD40 Ligand Interactions Promote Trafficking of CD8+ T Cells into the Brain and Protection against West Nile Virus Encephalitis Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus Identification of Novel Small-Molecule Inhibitors of West Nile Virus Infection A Critical Role for Induced IgM in the Protection against West Nile Virus Infection Genetically delivered antibody protects against West Nile virus The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis The structural immunology of antibody protection against West Nile virus The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection Defining the levels of secreted non-structural protein NS1 after West Nile virus infection in cell culture and mice Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step Progress on the development of therapeutics against West Nile virus Identification of Inhibitors of Yellow Fever Virus Replication Using a Replicon-Based High-Throughput Assay Key role of T cell defects in age-related vulnerability to West Nile virus Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1 West Nile virus meningoencephalitis Equine Immunoglobulin and Equine Neutralizing F(ab')₂ Protect Mice from West Nile Virus Infection A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer model A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis Role of CD8+ T cells in control of West Nile virus infection Generation and analysis of novel plant-derived antibody-based therapeutic molecules against West Nile virus.Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses.Identification and characterization of inhibitors of West Nile virus.Human Monoclonal Fab Antibodies Against West Nile Virus and its Neutralizing Activity Analyzed in Vitro and in Vivo Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology.

P2860

Q24261118-2F106334-4194-4DAF-9C0A-8031E36B91AB Q27469834-3B91473C-5037-4D97-9F71-D89C0EB0D357 Q27470828-6E58E20A-FB54-4F8A-AB30-2D5FCBAC3243 Q27472711-7AB6FC69-4B9F-460A-9702-F6487C9084C3 Q27472780-EAF240C8-2A47-445B-A29A-CFF5AA91D75B Q27472823-8A4CB405-66BF-4776-8E34-99A9100AE8CE Q27473186-BE48A7DB-DC46-4976-AE4D-10702D2DEA74 Q27473224-913FB30F-70C8-42F7-8821-F3041CBFB026 Q27473288-9E2545A7-01F2-4435-9E44-22245E2146A9 Q27477717-DD14C68F-DC56-4EEB-B4A1-49574A9786DC Q27477718-D818066B-92BA-4290-AABA-4568DA3C10BF Q27480795-4581D62C-A048-4690-AACB-2286943E1453 Q27481468-26FE2040-EB50-4523-A06F-DA016A2988F3 Q27484980-CDF7EA26-0A30-49D6-9ADD-086E2FEDB621 Q27484983-0C05B063-C9B3-4D17-98D4-274B19BC8AB7 Q27485124-36A5B277-7FB9-4FE3-82BA-EFA591FFC322 Q27485481-EA7D9537-B9B6-46D3-A50C-A72EAB7EE9F3 Q27486421-5985F151-E3CB-443E-9194-FBEC51B51E6A Q27486590-763529FD-EDF8-4615-AF96-C6F00DF4CF0D Q27487955-62CE8A36-8ED6-4E32-B6B2-ADDB5770AEF6 Q27488224-C5ECA3A9-064C-40AD-AB24-DA8BBCB73312 Q27488247-BAB21122-FCC3-44ED-97E2-704346A85FA3 Q27488750-B89C9C80-ADAC-4DB6-8692-76E5C4BAC55C Q27488791-60402424-3B4A-40F5-AADC-288DD07E664D Q27489893-4BC9A34D-041E-42BE-924C-06E4CE28A8CC Q27490191-5FFDAE46-18C5-41DA-AB63-6446CD7FD136 Q27490802-5939CAA6-5915-44F1-A1AC-02E3E5CC1BF4 Q27490937-F75062C6-1E75-4E77-9D74-870F0BFD846F Q27491317-DEC7A59B-EA5C-47CF-B6FC-BB943B308A44 Q28260103-FA3CB124-3BA2-4490-AC96-7F4626016581 Q28353948-D18D00D4-7863-44AB-86F1-08001ECC1E31 Q28740740-08DF03C7-F879-44D5-AADA-E1D0B3FFA741 Q28741304-A41415E4-37DE-458F-8A5B-2F70F98142A9 Q28804076-A6484827-9C34-48C2-8C55-BE37C4272CB4 Q29619668-B380FEBA-10E5-4BD9-A385-4DF75A64200C Q31154829-D6D402BA-6137-401C-AFD5-30E0F1823151 Q33208947-1A003132-B969-4FE0-8074-56A34244A53E Q33462229-4C5F1B9D-58C9-4E36-92A0-42A19F16A44D Q33588683-5C7319F7-AFA8-4811-B13E-DA8C46E5591D Q33610555-99D04C8E-4A43-444E-9672-26A55CE13D8E

P2860

Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice.

http://www.wikidata.org/entity/Q40344535

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Antibody prophylaxis and thera ...... type and immunodeficient mice.

@en

type

label

Antibody prophylaxis and thera ...... type and immunodeficient mice.

@en

prefLabel

Antibody prophylaxis and thera ...... type and immunodeficient mice.

@en

P1433

Q40344535-8B792B91-C698-4E51-8C21-3A9CD1E84ED9

P1476

Q40344535-BA1946E3-A4C4-4CFD-A481-2F76304FC8AE

P2093

Q40344535-7D9FE94F-7334-4241-BD00-C22859F22AD6

P2860

Q40344535-071C4F08-6D62-4F5C-8322-2D2934F0B48B

Q40344535-0998B0B4-5F30-409E-9742-4FB79F19CBA3

Q40344535-14CAE5F9-DD70-4A84-B847-62A3DBE72538

Q40344535-1843AB74-B844-4548-81B5-F64569744AF5

Q40344535-19DAFB07-1703-4FF6-943E-D8077090590B

Q40344535-1C00B5E3-056B-404C-A0B2-52217892139F

Q40344535-1FE3C2A0-4094-4C97-A52D-E65CCB1F9192

Q40344535-24328A25-35DD-417B-A067-33D8A5EE1AD6

Q40344535-288D08E7-DFC5-4C87-9186-D8E3C616781F

Q40344535-2933616B-26C9-47EC-9A3E-3CCE6913A999

P304

Q40344535-A654538B-EC5B-4D1C-95E7-432256AAC0C7

P31

Q40344535-34854D53-26B2-4B22-A672-30701217E940

P356

Q40344535-E7FC3480-21A9-4484-A658-C0A7153E2B19

P407

Q40344535-BF6B8063-DBF2-4794-BD4A-8DAF9DFAE04C

P433

Q40344535-CBFFACFF-B9C4-47F4-984F-DE4AF658295E

P478

Q40344535-42DE216E-27D1-4AC7-B9DF-720A49EF2CBB

P50

Q40344535-E51CC524-E5A6-4AB4-89CA-A3BD69D3EA84

P577

Q40344535-EA80C281-BA40-49E4-81CE-4C513467F2DF

P698

Q40344535-32603DCB-AF39-429A-A702-FA8EBA1DB940

P921

Q40344535-8C7995D1-8D94-4A9F-B6AA-EA8E716FB3B1

Q40344535-9D0E7FD8-1FCB-47C1-9F6B-8B2E2217B062

P932

Q40344535-B695F22E-EAC2-4DEC-94F2-1DA2A0AAEAA2

P356

JVI.77.24.12941-12949.2003

P1433

Journal of Virology

P1476

Antibody prophylaxis and thera ...... type and immunodeficient mice.

@en

P2093

Michael J Engle

http://www.w3.org/2001/XMLSchema#string

P2860

Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons.

Infection of human cells by dengue virus is modulated by different cell types and viral strains

B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

Japanese encephalitis virus latency in peripheral blood lymphocytes and recurrence of infection in children

Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model

West Nile Virus infection in mice following exposure to a viral aerosol

Langat virus encephalitis in mice. I. The effect of the administration of specific antiserum

Complement receptor mediates enhanced flavivirus replication in macrophages

Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis

Interaction of West Nile virus with primary murine macrophages: role of cell activation and receptors for antibody and complement

P304

12941-12949

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.77.24.12941-12949.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

77

http://www.w3.org/2001/XMLSchema#string

P50

Michael S. Diamond

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14645550

http://www.w3.org/2001/XMLSchema#string

P921

West Nile virus

P932

296058

http://www.w3.org/2001/XMLSchema#string